Study of Nitazoxanide (NTZ) Based New Therapeutic Regimens for Helicobacter Pylori

Trial Profile

Study of Nitazoxanide (NTZ) Based New Therapeutic Regimens for Helicobacter Pylori

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 06 Dec 2017

At a glance

  • Drugs Nitazoxanide (Primary) ; Clarithromycin; Doxycycline; Levofloxacin; Metronidazole; Omeprazole
  • Indications Helicobacter pylori infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Dec 2017 Status changed to active, no longer recruiting.
    • 01 Nov 2017 Results assessing the efficacy and safety of a unique triple Nitazoxanide containing regimen presented at the 25th United European Gastroenterology Week
    • 24 Apr 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top